Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.58
ANGO's Cash-to-Debt is ranked lower than
69% of the 205 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. ANGO: 0.58 )
Ranked among companies with meaningful Cash-to-Debt only.
ANGO' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.07  Med: 3.98 Max: 30.91
Current: 0.58
0.07
30.91
Equity-to-Asset 0.77
ANGO's Equity-to-Asset is ranked higher than
73% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. ANGO: 0.77 )
Ranked among companies with meaningful Equity-to-Asset only.
ANGO' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.06  Med: 0.83 Max: 0.94
Current: 0.77
0.06
0.94
Debt-to-Equity 0.17
ANGO's Debt-to-Equity is ranked higher than
67% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.37 vs. ANGO: 0.17 )
Ranked among companies with meaningful Debt-to-Equity only.
ANGO' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02  Med: 0.07 Max: 13.13
Current: 0.17
0.02
13.13
Debt-to-EBITDA 2.12
ANGO's Debt-to-EBITDA is ranked lower than
82% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. ANGO: 2.12 )
Ranked among companies with meaningful Debt-to-EBITDA only.
ANGO' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.21  Med: 2.38 Max: 15.37
Current: 2.12
0.21
15.37
Interest Coverage 7.76
ANGO's Interest Coverage is ranked lower than
99.99% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.92 vs. ANGO: 7.76 )
Ranked among companies with meaningful Interest Coverage only.
ANGO' s Interest Coverage Range Over the Past 10 Years
Min: 4.11  Med: 8.88 Max: 38.37
Current: 7.76
4.11
38.37
Piotroski F-Score: 8
Altman Z-Score: 3.59
Beneish M-Score: -2.64
WACC vs ROIC
8.63%
-0.66%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 6.58
ANGO's Operating Margin % is ranked lower than
60% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.41 vs. ANGO: 6.58 )
Ranked among companies with meaningful Operating Margin % only.
ANGO' s Operating Margin % Range Over the Past 10 Years
Min: 4.11  Med: 6.78 Max: 9.75
Current: 6.58
4.11
9.75
Net Margin % 0.38
ANGO's Net Margin % is ranked lower than
63% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.18 vs. ANGO: 0.38 )
Ranked among companies with meaningful Net Margin % only.
ANGO' s Net Margin % Range Over the Past 10 Years
Min: -12.32  Med: 1.05 Max: 6.54
Current: 0.38
-12.32
6.54
ROE % 0.25
ANGO's ROE % is ranked lower than
62% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.43 vs. ANGO: 0.25 )
Ranked among companies with meaningful ROE % only.
ANGO' s ROE % Range Over the Past 10 Years
Min: -8.28  Med: 0.71 Max: 3.22
Current: 0.25
-8.28
3.22
ROA % 0.19
ANGO's ROA % is ranked lower than
60% of the 206 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. ANGO: 0.19 )
Ranked among companies with meaningful ROA % only.
ANGO' s ROA % Range Over the Past 10 Years
Min: -5.81  Med: 0.5 Max: 2.96
Current: 0.19
-5.81
2.96
ROC (Joel Greenblatt) % 21.56
ANGO's ROC (Joel Greenblatt) % is ranked lower than
62% of the 204 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.63 vs. ANGO: 21.56 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ANGO' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -5.21  Med: 14.53 Max: 30.62
Current: 21.56
-5.21
30.62
3-Year Revenue Growth Rate -1.80
ANGO's 3-Year Revenue Growth Rate is ranked lower than
71% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. ANGO: -1.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ANGO' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -1.8  Med: 7.4 Max: 25.2
Current: -1.8
-1.8
25.2
3-Year EBITDA Growth Rate 8.70
ANGO's 3-Year EBITDA Growth Rate is ranked lower than
72% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.00 vs. ANGO: 8.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ANGO' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 4.65 Max: 48
Current: 8.7
0
48
3-Year EPS without NRI Growth Rate 26.00
ANGO's 3-Year EPS without NRI Growth Rate is ranked higher than
72% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.90 vs. ANGO: 26.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ANGO' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -9.45 Max: 100
Current: 26
0
100
GuruFocus has detected 6 Warning Signs with AngioDynamics Inc ANGO.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ANGO's 30-Y Financials

Financials (Next Earnings Date: 2018-07-18)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2017

ANGO Guru Trades in Q2 2017

Paul Tudor Jones 47,570 sh (+68.09%)
Joel Greenblatt 79,021 sh (+43.99%)
Jim Simons 673,710 sh (+33.09%)
Chuck Royce 938,148 sh (+15.78%)
Mario Gabelli 52,000 sh (-13.33%)
» More
Q3 2017

ANGO Guru Trades in Q3 2017

Chuck Royce 965,157 sh (+2.88%)
Mario Gabelli 50,000 sh (-3.85%)
Paul Tudor Jones 39,441 sh (-17.09%)
Jim Simons 459,500 sh (-31.80%)
Joel Greenblatt 49,193 sh (-37.75%)
» More
Q4 2017

ANGO Guru Trades in Q4 2017

Jim Simons 541,800 sh (+17.91%)
Chuck Royce 1,098,817 sh (+13.85%)
Mario Gabelli 50,000 sh (unchged)
Paul Tudor Jones 30,168 sh (-23.51%)
Joel Greenblatt 27,707 sh (-43.68%)
» More
Q1 2018

ANGO Guru Trades in Q1 2018

Jim Simons 641,100 sh (+18.33%)
Chuck Royce 1,119,808 sh (+1.91%)
Mario Gabelli 50,000 sh (unchged)
Joel Greenblatt Sold Out
Paul Tudor Jones Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with ANGO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2018-03-31 Sold Out 0.01%$15.71 - $17.7 $ 22.0932%0
Joel Greenblatt 2017-12-31 Reduce -43.68%$16.56 - $17.8 $ 22.0929%27,707
Mario Gabelli 2017-09-30 Reduce -3.85%$15.12 - $18.76 $ 22.0932%50,000
Joel Greenblatt 2017-09-30 Reduce -37.75%0.01%$15.12 - $18.76 $ 22.0932%49,193
Joel Greenblatt 2017-06-30 Add 43.99%0.01%$15.08 - $17.35 $ 22.0940%79,021
Mario Gabelli 2017-06-30 Reduce -13.33%$15.08 - $17.35 $ 22.0940%52,000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:XKRX:048260, SHSE:600288, NAS:STAA, TSE:4218, NAS:ATRC, OSTO:BIOT, SZSE:002432, SHSE:603987, SZSE:300171, XKRX:145720, NAS:ENTL, NAS:LMAT, XKRX:039840, XKRX:041830, TSE:7743, ASX:NAN, SZSE:300358, TSE:7780, LSE:AMS, OSTO:ALIF B » details
Traded in other countries:UG2.Germany,
Headquarter Location:USA
AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.

AngioDynamics Inc manufactures medical, surgical, and diagnostic devices. It sells products in three categories: peripheral vascular, vascular access, and oncology/surgery. The peripheral vascular products contribute the largest proportion of revenue and include fluid management, venous, drainage, angiographic, and thrombus management products. The firm's vascular access products are used during image-guided vascular access procedures, which place catheters into the central venous system. These products include peripherally inserted central catheters, port products, and dialysis products. Its oncology/surgery products include microwave ablation, radiofrequency ablation, and NanoKnife product lines. AngioDynamics generates the majority of its revenue in the United States.

Top Ranked Articles about AngioDynamics Inc

Research Report Identifies AngioDynamics, Kaiser Aluminum, Mammoth Energy Services, Meridian Bioscience, Merrimack Pharmaceuticals, and Energizer with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Recent Analysis Shows Multi-Color, Madrigal Pharmaceuticals, SPX, AngioDynamics, Atara Biotherapeutics, and Quanex Building Products Market Influences — Renewed Outlook, Key Drivers of Growth
Investor Expectations to Drive Momentum within Regal Beloit, Kaiser Aluminum, AngioDynamics, Mulesoft, Assembly Biosciences, and Woodward — Discovering Underlying Factors of Influence
Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open
AngioDynamics to Report Fiscal 2018 First Quarter Financial Results
AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
AngioDynamics to Present at the 2017 Morgan Stanley Global Healthcare Conference
AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference
INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of AngioDynamics, Inc. - ANGO
Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., Repros Therapeutics Inc. and Tahoe Resources Inc.

Ratios

vs
industry
vs
history
PE Ratio 736.29
ANGO's PE Ratio is ranked lower than
99.99% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.70 vs. ANGO: 736.29 )
Ranked among companies with meaningful PE Ratio only.
ANGO' s PE Ratio Range Over the Past 10 Years
Min: 14.91  Med: 38.98 Max: 737.95
Current: 736.29
14.91
737.95
Forward PE Ratio 24.81
ANGO's Forward PE Ratio is ranked higher than
80% of the 40 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.32 vs. ANGO: 24.81 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 736.29
ANGO's PE Ratio without NRI is ranked lower than
99.99% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. ANGO: 736.29 )
Ranked among companies with meaningful PE Ratio without NRI only.
ANGO' s PE Ratio without NRI Range Over the Past 10 Years
Min: 14.91  Med: 38.98 Max: 737.95
Current: 736.29
14.91
737.95
Price-to-Owner-Earnings 35.78
ANGO's Price-to-Owner-Earnings is ranked higher than
73% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.92 vs. ANGO: 35.78 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ANGO' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 11.07  Med: 23.83 Max: 437.5
Current: 35.78
11.07
437.5
PB Ratio 1.51
ANGO's PB Ratio is ranked higher than
86% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.45 vs. ANGO: 1.51 )
Ranked among companies with meaningful PB Ratio only.
ANGO' s PB Ratio Range Over the Past 10 Years
Min: 0.64  Med: 0.97 Max: 1.51
Current: 1.51
0.64
1.51
PS Ratio 2.36
ANGO's PS Ratio is ranked higher than
67% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.48 vs. ANGO: 2.36 )
Ranked among companies with meaningful PS Ratio only.
ANGO' s PS Ratio Range Over the Past 10 Years
Min: 1.03  Med: 1.67 Max: 3.49
Current: 2.36
1.03
3.49
Price-to-Free-Cash-Flow 24.92
ANGO's Price-to-Free-Cash-Flow is ranked higher than
80% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.61 vs. ANGO: 24.92 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ANGO' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.81  Med: 19.26 Max: 338.64
Current: 24.92
8.81
338.64
Price-to-Operating-Cash-Flow 22.41
ANGO's Price-to-Operating-Cash-Flow is ranked higher than
73% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.15 vs. ANGO: 22.41 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ANGO' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.43  Med: 13.94 Max: 69.89
Current: 22.41
8.43
69.89
EV-to-EBIT 42.54
ANGO's EV-to-EBIT is ranked lower than
99.99% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.93 vs. ANGO: 42.54 )
Ranked among companies with meaningful EV-to-EBIT only.
ANGO' s EV-to-EBIT Range Over the Past 10 Years
Min: -253.2  Med: 22.1 Max: 2726.8
Current: 42.54
-253.2
2726.8
EV-to-EBITDA 19.46
ANGO's EV-to-EBITDA is ranked lower than
77% of the 138 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.49 vs. ANGO: 19.46 )
Ranked among companies with meaningful EV-to-EBITDA only.
ANGO' s EV-to-EBITDA Range Over the Past 10 Years
Min: -536.4  Med: 13.3 Max: 52.8
Current: 19.46
-536.4
52.8
EV-to-Revenue 2.44
ANGO's EV-to-Revenue is ranked higher than
69% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.57 vs. ANGO: 2.44 )
Ranked among companies with meaningful EV-to-Revenue only.
ANGO' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.7  Med: 1.8 Max: 3.4
Current: 2.44
0.7
3.4
PEG Ratio 33.39
ANGO's PEG Ratio is ranked lower than
99.99% of the 69 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.70 vs. ANGO: 33.39 )
Ranked among companies with meaningful PEG Ratio only.
ANGO' s PEG Ratio Range Over the Past 10 Years
Min: 4.25  Med: 8.38 Max: 78.72
Current: 33.39
4.25
78.72
Shiller PE Ratio 516.41
ANGO's Shiller PE Ratio is ranked lower than
98% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.97 vs. ANGO: 516.41 )
Ranked among companies with meaningful Shiller PE Ratio only.
ANGO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 41.92  Med: 87.5 Max: 578.33
Current: 516.41
41.92
578.33
Current Ratio 2.88
ANGO's Current Ratio is ranked lower than
51% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.57 vs. ANGO: 2.88 )
Ranked among companies with meaningful Current Ratio only.
ANGO' s Current Ratio Range Over the Past 10 Years
Min: 1.95  Med: 3.66 Max: 14.28
Current: 2.88
1.95
14.28
Quick Ratio 1.84
ANGO's Quick Ratio is ranked lower than
55% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. ANGO: 1.84 )
Ranked among companies with meaningful Quick Ratio only.
ANGO' s Quick Ratio Range Over the Past 10 Years
Min: 1.16  Med: 3.03 Max: 12.12
Current: 1.84
1.16
12.12
Days Inventory 118.67
ANGO's Days Inventory is ranked higher than
57% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.35 vs. ANGO: 118.67 )
Ranked among companies with meaningful Days Inventory only.
ANGO' s Days Inventory Range Over the Past 10 Years
Min: 115.59  Med: 127.32 Max: 158.59
Current: 118.67
115.59
158.59
Days Sales Outstanding 44.53
ANGO's Days Sales Outstanding is ranked higher than
79% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.97 vs. ANGO: 44.53 )
Ranked among companies with meaningful Days Sales Outstanding only.
ANGO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.53  Med: 52.72 Max: 79.92
Current: 44.53
44.53
79.92
Days Payable 34.87
ANGO's Days Payable is ranked lower than
58% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 54.66 vs. ANGO: 34.87 )
Ranked among companies with meaningful Days Payable only.
ANGO' s Days Payable Range Over the Past 10 Years
Min: 31.74  Med: 50.44 Max: 110.32
Current: 34.87
31.74
110.32

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.30
ANGO's 3-Year Average Share Buyback Ratio is ranked higher than
65% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -5.00 vs. ANGO: -1.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ANGO' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -29  Med: -10.6 Max: -1
Current: -1.3
-29
-1

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 19.21
ANGO's Price-to-Tangible-Book is ranked lower than
95% of the 167 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.77 vs. ANGO: 19.21 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ANGO' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.58  Med: 3.5 Max: 263.11
Current: 19.21
1.58
263.11
Price-to-Intrinsic-Value-Projected-FCF 1.25
ANGO's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
85% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. ANGO: 1.25 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ANGO' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.54  Med: 0.89 Max: 1.26
Current: 1.25
0.54
1.26
Price-to-Median-PS-Value 1.43
ANGO's Price-to-Median-PS-Value is ranked higher than
52% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.13 vs. ANGO: 1.43 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ANGO' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.67  Med: 1.03 Max: 3.06
Current: 1.43
0.67
3.06
Price-to-Peter-Lynch-Fair-Value 81.81
ANGO's Price-to-Peter-Lynch-Fair-Value is ranked lower than
99.99% of the 45 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.46 vs. ANGO: 81.81 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
ANGO' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 1.14  Med: 2.36 Max: 82
Current: 81.81
1.14
82
Price-to-Graham-Number 25.69
ANGO's Price-to-Graham-Number is ranked lower than
99.99% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. ANGO: 25.69 )
Ranked among companies with meaningful Price-to-Graham-Number only.
ANGO' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.55  Med: 2.13 Max: 25.74
Current: 25.69
1.55
25.74
Earnings Yield (Greenblatt) % 2.39
ANGO's Earnings Yield (Greenblatt) % is ranked lower than
63% of the 207 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. ANGO: 2.39 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ANGO' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -2.4  Med: 2.9 Max: 10.9
Current: 2.39
-2.4
10.9
Forward Rate of Return (Yacktman) % 12.91
ANGO's Forward Rate of Return (Yacktman) % is ranked higher than
50% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.66 vs. ANGO: 12.91 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ANGO' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -15.5  Med: 2.9 Max: 24.4
Current: 12.91
-15.5
24.4

More Statistics

Revenue (TTM) (Mil) $342.88
EPS (TTM) $ 0.03
Beta0.73
Volatility18.43%
52-Week Range $14.97 - 21.85
Shares Outstanding (Mil)36.80

Analyst Estimate

May18 May19 May20 May21
Revenue (Mil $) 347 351 363 375
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) 0.64 0.41 0.45 0.50
EPS without NRI ($) 0.64 0.41 0.45 0.50
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 88
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}